FindTrial
Sign In

The research of therapeutic effect and mechanisms of Huyuqingrelishi on DVT by regulating DC function via targeting Jak/STAT signaling pathway

The research of therapeutic effect and mechanisms of Huyuqingrelishi on DVT by regulating DC function via targeting Jak/STAT signaling pathway

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018867
Enrollment
Unknown
Registered
2018-10-14
Start date
2018-10-12
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis

Interventions

Normal control:No
DVT group:Herbs

Sponsors

Af?liated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Acute stage of mixed pure lower extremity deep venous thrombosis; 2. One limb of deep venous thrombosis; 3. The duration is within 15 days.

Exclusion criteria

Exclusion criteria: 1. Have hemorrhagic disease or bleeding tendency; 2. Patients who are participating in other clinical trials; 3. Other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Immunocyte;Vessel;Cytokine;D-dimer;microRNA;LncRNA;circleRNA;mRNA;Ultrasonic B;—

Countries

China

Contacts

Public ContactBin Wang

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

2801505631@qq.com+86 13589040205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026